🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the safety and efficacy of NB-0...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-04
Trial ID
NCT01324466
The aim of this study is to determine the safety and efficacy of a topical ...
Status
Unknown
Location
Evalulab Inc
Start Date
2016-01
Trial ID
NCT02582086
Treatments Being Tested
Experimental clinical study with a post-marketing, prospective, intra-subje...
Status
Completed
Location
Centro Médico Complutense Grupo Virtus
Start Date
2022-12-13
Trial ID
NCT06734728
Treatments Being Tested
This will be a randomized, efficacy assessor-blinded, parallel group, pilot...
Status
Completed
Location
University of Utah MidValley Dermatology
Start Date
2024-08-19
Trial ID
NCT06558838
Treatments Being Tested
The purpose of this study is to evaluate the episode duration of a herpes l...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00735761
Treatments Being Tested
To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for ...
Status
Completed
Location
MCS Clinical Trials
Start Date
2012-03
Trial ID
NCT01574612
Treatments Being Tested
Lesions of herpes labialis are caused by the herpes simplex virus type 1 (H...
Status
Completed
Location
Anna Carolina R.T. Horliana
Start Date
2020-01-01
Trial ID
NCT04037475
Treatments Being Tested
Background: \- Viral infections are an important cause of illness and deat...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2011-03-15
Trial ID
NCT01306084
This study will assess the safety, tolerability of a single 1500 mg dose of...
Status
Completed
Location
Women's Health Care at Frost Street
Start Date
2009-03-25
Trial ID
NCT00878072
Treatments Being Tested
Primary Objective: To assess local and generalized adverse events with repe...
Status
Terminated
Location
International Research Partners, LLC
Start Date
2018-03-12
Trial ID
NCT03521479
Treatments Being Tested